Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:7800219rdf:typepubmed:Citationlld:pubmed
pubmed-article:7800219lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:7800219lifeskim:mentionsumls-concept:C0022646lld:lifeskim
pubmed-article:7800219lifeskim:mentionsumls-concept:C0450127lld:lifeskim
pubmed-article:7800219lifeskim:mentionsumls-concept:C0040053lld:lifeskim
pubmed-article:7800219lifeskim:mentionsumls-concept:C0205217lld:lifeskim
pubmed-article:7800219lifeskim:mentionsumls-concept:C0031140lld:lifeskim
pubmed-article:7800219pubmed:issue8lld:pubmed
pubmed-article:7800219pubmed:dateCreated1995-1-23lld:pubmed
pubmed-article:7800219pubmed:abstractTextIn a retrospective analysis of 202 renal transplant procedures in the years 1989-1992 we identified an excess of grafts lost from primary renovascular thrombosis in patients receiving continuous ambulatory peritoneal dialysis (CAPD) compared to haemodialysis (HD) patients (9 CAPD versus 0 HD, Chi-squared = 9.63; P < 0.01). All graft losses from thrombosis occurred within 16 days of surgery. Possible predisposing causes were identified in three patients. Donor age was greater in CAPD patients losing their kidneys from thrombosis compared to the overall CAPD group [mean (SD) years, 43.0(12.9) versus 29.1(15.8); P = 0.01] whereas no significant difference in haematocrit, platelet count, antibody status, cyclosporin use, peroperative hypotension, primary diagnosis, smoking, or diabetes mellitus was found. Data from the EDTA registry for 1990-91 show that graft loss from primary renovascular thrombosis in UK-treated patients was reported in 7.1% of CAPD recipients compared with 1.8% in haemodialysis. We suggest that CAPD patients are at greater risk of graft loss from renovascular thrombosis than HD patients and may require more intensive fluid and anticoagulant treatment in the perioperative period.lld:pubmed
pubmed-article:7800219pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7800219pubmed:languageenglld:pubmed
pubmed-article:7800219pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7800219pubmed:citationSubsetIMlld:pubmed
pubmed-article:7800219pubmed:statusMEDLINElld:pubmed
pubmed-article:7800219pubmed:issn0931-0509lld:pubmed
pubmed-article:7800219pubmed:authorpubmed-author:BrownJ HJHlld:pubmed
pubmed-article:7800219pubmed:authorpubmed-author:DohertyC CCClld:pubmed
pubmed-article:7800219pubmed:authorpubmed-author:MiddletonDDlld:pubmed
pubmed-article:7800219pubmed:authorpubmed-author:HillC MCMlld:pubmed
pubmed-article:7800219pubmed:authorpubmed-author:DouglasJ FJFlld:pubmed
pubmed-article:7800219pubmed:authorpubmed-author:NelsonW EWElld:pubmed
pubmed-article:7800219pubmed:authorpubmed-author:MurphyB GBGlld:pubmed
pubmed-article:7800219pubmed:authorpubmed-author:McNameeP TPTlld:pubmed
pubmed-article:7800219pubmed:authorpubmed-author:KernohanR MRMlld:pubmed
pubmed-article:7800219pubmed:authorpubmed-author:KeaneP KPKlld:pubmed
pubmed-article:7800219pubmed:issnTypePrintlld:pubmed
pubmed-article:7800219pubmed:volume9lld:pubmed
pubmed-article:7800219pubmed:ownerNLMlld:pubmed
pubmed-article:7800219pubmed:authorsCompleteYlld:pubmed
pubmed-article:7800219pubmed:pagination1166-9lld:pubmed
pubmed-article:7800219pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:7800219pubmed:meshHeadingpubmed-meshheading:7800219-...lld:pubmed
pubmed-article:7800219pubmed:meshHeadingpubmed-meshheading:7800219-...lld:pubmed
pubmed-article:7800219pubmed:meshHeadingpubmed-meshheading:7800219-...lld:pubmed
pubmed-article:7800219pubmed:meshHeadingpubmed-meshheading:7800219-...lld:pubmed
pubmed-article:7800219pubmed:meshHeadingpubmed-meshheading:7800219-...lld:pubmed
pubmed-article:7800219pubmed:meshHeadingpubmed-meshheading:7800219-...lld:pubmed
pubmed-article:7800219pubmed:meshHeadingpubmed-meshheading:7800219-...lld:pubmed
pubmed-article:7800219pubmed:meshHeadingpubmed-meshheading:7800219-...lld:pubmed
pubmed-article:7800219pubmed:meshHeadingpubmed-meshheading:7800219-...lld:pubmed
pubmed-article:7800219pubmed:meshHeadingpubmed-meshheading:7800219-...lld:pubmed
pubmed-article:7800219pubmed:meshHeadingpubmed-meshheading:7800219-...lld:pubmed
pubmed-article:7800219pubmed:meshHeadingpubmed-meshheading:7800219-...lld:pubmed
pubmed-article:7800219pubmed:meshHeadingpubmed-meshheading:7800219-...lld:pubmed
pubmed-article:7800219pubmed:meshHeadingpubmed-meshheading:7800219-...lld:pubmed
pubmed-article:7800219pubmed:meshHeadingpubmed-meshheading:7800219-...lld:pubmed
pubmed-article:7800219pubmed:meshHeadingpubmed-meshheading:7800219-...lld:pubmed
pubmed-article:7800219pubmed:year1994lld:pubmed
pubmed-article:7800219pubmed:articleTitleIncreased renal allograft thrombosis in CAPD patients.lld:pubmed
pubmed-article:7800219pubmed:affiliationRegional Nephrology Unit, Belfast City Hospital, Northern Ireland, UK.lld:pubmed
pubmed-article:7800219pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:7800219pubmed:publicationTypeComparative Studylld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7800219lld:pubmed